We subsequently tested the effect of the insulin-sensitizing agent metformin, a widely prescribed medication that is considered first-line treatment for DM2 [26], on our fly model of obesity and disseminated mucormycosis. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.